Astrana Health Debt to Equity Ratio 2016-2026 | ASTH
Current and historical debt to equity ratio values for Astrana Health (ASTH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Astrana Health debt/equity for the three months ending June 30, 2026 was 1.05.
| Astrana Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $1.44B | $0.84B | 1.71 |
| 2026-03-31 | $1.54B | $0.82B | 1.89 |
| 2025-12-31 | $1.43B | $0.79B | 1.80 |
| 2025-09-30 | $1.45B | $0.79B | 1.84 |
| 2025-06-30 | $0.67B | $0.77B | 0.87 |
| 2025-03-31 | $0.58B | $0.75B | 0.77 |
| 2024-12-31 | $0.64B | $0.72B | 0.89 |
| 2024-09-30 | $0.58B | $0.71B | 0.81 |
| 2024-06-30 | $0.57B | $0.68B | 0.83 |
| 2024-03-31 | $0.57B | $0.66B | 0.86 |
| 2023-12-31 | $0.32B | $0.62B | 0.51 |
| 2023-09-30 | $0.48B | $0.60B | 0.80 |
| 2023-06-30 | $0.46B | $0.57B | 0.80 |
| 2023-03-31 | $0.45B | $0.55B | 0.81 |
| 2022-12-31 | $0.42B | $0.54B | 0.78 |
| 2022-09-30 | $0.43B | $0.51B | 0.84 |
| 2022-06-30 | $0.47B | $0.49B | 0.96 |
| 2022-03-31 | $0.43B | $0.48B | 0.90 |
| 2021-12-31 | $0.41B | $0.45B | 0.91 |
| 2021-09-30 | $0.43B | $0.44B | 0.98 |
| 2021-06-30 | $0.49B | $0.41B | 1.21 |
| 2021-03-31 | $0.49B | $0.35B | 1.41 |
| 2020-12-31 | $0.49B | $0.33B | 1.47 |
| 2020-09-30 | $0.59B | $0.23B | 2.55 |
| 2020-06-30 | $0.63B | $0.21B | 3.01 |
| 2020-03-31 | $0.53B | $0.20B | 2.66 |
| 2019-12-31 | $0.54B | $0.19B | 2.79 |
| 2019-09-30 | $0.56B | $0.19B | 2.90 |
| 2019-06-30 | $0.38B | $0.19B | 2.05 |
| 2019-03-31 | $0.34B | $0.18B | 1.86 |
| 2018-12-31 | $0.33B | $0.18B | 1.83 |
| 2018-09-30 | $0.37B | $0.19B | 1.98 |
| 2018-06-30 | $0.34B | $0.18B | 1.92 |
| 2018-03-31 | $0.35B | $0.17B | 2.06 |
| 2017-12-31 | $0.33B | $0.16B | 1.99 |
| 2017-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-06-30 | $0.00B | $0.00B | 0.00 |
| 2017-03-31 | $0.02B | $0.00B | 75.44 |
| 2016-12-31 | $0.26B | $0.09B | 3.00 |
| 2016-03-31 | $0.01B | $0.01B | 1.29 |
| 2015-03-31 | $0.02B | $0.00B | -16.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |